NeutraSal®                                   
W E L C O M E   t o   N e u t r a S a l ®

#1 Product for Treatment of Oral Mucositis in the U.S.*

"I am having radiation treatments at the Cancer Center on Vernon Ave. in Bloomington and they recommended NeutraSal. It has been a life saver for me! Really has helped. I have very few sores in my mouth, and I believe NeutraSal has helped prevent more.” —Mary Bigger, cancer patient



"My patients love this product!"  
—Cathy D. RN, South Florida Radiation Oncology, Wellington, FL

_____________________________________________________________________________________________________________

Invado Pharmaceuticals LLC
is a privately-held LLC headquartered in Pomona, NY. The founders and advisory board have over 100 years of collective experience in the Pharmaceutical Industry.

MISSION STATEMENT: Improve the lives of patients, families and health care providers by offering high quality, cost effective medical devices and pharmaceuticals, with primary focus on the supportive care side of Oncology.

NeutraSal® received marketing clearance in the United States by the Food and Drug Administration (FDA) in December 2009. Invado Pharmaceuticals LLC has multiple products in the R+D pipeline and is currently in negotiations with marketing partners for commercialization outside the U.S. including the EU and Asia.

For more information, contact us 866-963-8881 or email us at inquiries@invadopharma.com

* Based on cumulative sales Q1-Q4, 2013.  IMS Data and Published Annual Sales.